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Structured Abstract 
Background: The RAD-MATRIX trial reported a largeoperator radiation exposure 
variability in right radial percutaneous coronary procedures. The reasons of these 
differences are not well understood. Our aim was toappraisethe determinants of 
operator radiation exposure during coronary right transradial procedures. 
Methods: Patient arrangement during trans-radial intervention was investigated 
across operators involved in the RAD-MATRIX trial. Operator radiation exposure 
was analyzed according to the position of the patient right arm (close or far from the 
body) and in relation to the size of the upper leaded glass. 
Results: Amongst the 14 operators who agreed to participate, there was a greater 
than 10-fold difference in radiation dose at thorax level (from 21.5 µSv to 267 µSv) 
that persisted after normalization by DAP (from 0.35 µSv/Gy*cm
2
 to 3.5 
µSv/Gy*cm
2
). Among the operators who positioned the instrumented right arm far 
from the body (110.4 µSv, Interquartile range 71.5-146.5 µSv) thorax dose was 
greater than those who placed the instrumented arm close to the right leg (46.1 µSv, 
31.3-56.8 µSv, p=0.02). This difference persisted after normalization by DAP 
(p=0.028). The use of a smaller full glass shield was also associated with a higher 
radiation exposure compared to a larger composite shield (147.5 µSv, and 60 µSv, 
respectively, p= 0.016). 
Conclusions: In thecontext of the biggest radiation study conducted in patients 
undergoing trans-radial catheterization, the instrumented right arm arrangement close 
to the leg and greater upper leaded shield dimensions were associated with a lower 
operator radiation exposure. Our findings emphasize the importance of implementing 
simple preventive measures to mitigate the extra risks of radiation exposure with 
right radial as compared with femoral access.  
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Introduction 
The use of radial, instead of femoral, access for coronary angiography and 
percutaneous coronary intervention (PCI) has recently gained worldwide acceptance 
due to lower risks of bleeding, vascular complications and patients discomfort (1-3). 
The MATRIX trial (1)showed a greater survival in patients with acute coronary 
syndrome undergoing invasive management treated by transradial rather than 
transfemoral approach. This observation, in conjunction with prior evidence, has led 
the European clinical practice guidelines to endorse the use of radial access in 
patients with acute coronary syndromes undergoing invasive management with a 
class I recommendation(4, 5). 
However, the right radial access site, which is by far the most frequently used 
transradial route worldwide, is associated to higher radiation exposure, especially for 
operators, as compared to the femoral approach (6-9). A possible explanation of the 
higher dose in radial access is due to the operators difficulty in adequately shield 
themselves from the scatter radiation coming from the patient. The use of adjunctive 
protective drapes placed on the patient have been proved to be effective methods to 
significantly reduce this scatter radiation coming from the patientreducing the 
operator radiation exposure in transradial procedures(10-11).  
A significant variability in operator radiation dose has been documented 
among operators performing transradial procedures in the largest study evaluating 
operator radiation exposure during percutaneous coronary interventions (12). The 
reasons of this heterogeneity are likely multifactorial (position of the operator, use of 
adequate shield, positioning of the shield, radiation dose utilized, etc.) but not 
completely understood. 
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At variance with the transfemoral approach, the arrangement for patients 
undergoing right radial access lacks standardization. In particular some operators 
position the patient right arm along to the patient right leg, whereas other operators 
prefer to undertake catheterization while the right arm lies abducted from the patient 
leg. These two different arrangements reflect a different positioning of the operator 
during the procedure and differential use of the upper mobile leaded glass. No 
studies,to date, evaluated therole of the different patient arrangements in terms of 
operator radiation dose.  
The aim of this analysis of the RAD-MATRIX study, is to appraise the 
determinants of operator radiation exposure during right transradial approach.  
 
Methods 
Study design and population 
The designs of the MATRIX trial and of the radiation (RAD-MATRIX) 
substudy have been previously reported (13,14). In brief, all patients with an ACS 
with or without ST-segment elevation myocardial infarction were randomly allocated 
to radial or femoral access.  
Operators participating in the radiation sub-study were asked to follow central 
randomization in regards to radial or femoral access for the primary endpoint 
comparison (operator radiation exposure at thorax), and for the patient radiation 
exposure comparison. A further randomization was performed in patients centrally 
allocated to radial access based on the patient identification (ID) number with odd ID 
numbers assigned to right radial and even ID numbers to left radial access. In the 
present analysis we considered only the right radial access procedures. 
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Procedures 
Access site management during and after the diagnostic or therapeutic 
procedure was left to the discretion of the treating physician. Patient and operator 
positioning during trans-radial catheterization was according to institutional 
standards. 
In all procedures, radioprotection was ensured using a lead apron, a thyroid 
lead collar, lower body X-ray curtain fixed on the angiographic table and an upper 
mobile leaded glass suspended from the ceiling.  
Radiation Measurement 
Each operator was equipped with dedicated lithium fluoride thermo-
luminescent dosimeters with a range of linearity from 1 µGy to 10 Gy placed at left 
wrist, at mid thorax level, in the breast pocket outside the lead apron and at head 
level (in the middle front to measure the eye dose). At the end of the study, all the 
dosimeters were collected for central reading at TECNORAD co. (Verona, Italy) and 
represent cumulative exposure during all procedures performed by the operator that 
were divided by the number of procedures performed in order to obtain the operator 
mean radiation dose. The results were expressed as Equivalent doses in microSievert 
after correction for the radiation weighting factor (for X rays this factor is 1).  
Procedural dose was estimated using the Dose Area Product (DAP) expressed 
in Gy*cm2. The DAP is the product of the absorbed dose to air and the cross-
sectional area of the X-ray field for all segments of an interventional radiology 
procedure. This parameter was measured using specially designed ionization 
chambers mounted at the collimator system and calculated by the software present in 
each angiographic system.  
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There were no significant differences in operator positioning in relation to the 
radiation source. 
Patient set-up and upper mobile leaded glass 
Description of patient set-up was performed asking to the operators involved 
in the study to take representative picturesillustrating the positions of patient’s right 
arm as well of the operators during trans-radial catheterization. After centralised 
analysis of each operator’s representative pictures, two different arrangements of the 
patient right arm were identified: straight close to the right leg (Group A) or far from 
the body (Group B, Figure 1). 
In addition two different upper mobile leaded shields were identified across 
participating centers: a full glass shield (60 cm of height) or a combined glass and 
curtain leaded shield (35 cm each for a total height of 70 cm, Figure 2). 
Statistical analysis 
Continuous variables are reported as mean and standard deviation and 
compared using T-Test. Categorical variables are indicated as the absolute number 
and percentage and were compared by Pearson’s chi-square test or, if the number 
expected of patients was less than five, with the Fisher’s exact test. 
Operator radiation doseand fluoroscopy time were presented as median with 
interquartile range and compared by Mann Whitney U test. The operator radiation 
dose was also normalized by DAP to exclude a possible bias due to the complexity 
of the procedure or to the anthropometric characteristics of the patients. 
The analyses were performed using SPSS 21.0 software (SPSS, Chicago, 
Illinois, USA). 
Endpoints 
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The primary end-point of the study was operator radiation exposure at thorax 
level during right radial procedures comparing the two arrangements of patient right 
arm (Group A vs B) as previously described. Secondary end-point was operator 
radiation exposure comparing the two identified upper mobile shields across 
participating institutions. 
Extramural funding 
The MATRIX program is conducted with support from The Medicines 
Company and Terumo.  
The RAD MATRIX sub-study did not receive additional funding and has 
been co-supported by Alessandro Sciahbasi, the sub-study principal investigator. 
The authors are solely responsible for the design and conduct of this study, all 
study analyses, the drafting and editing of the paper and its final contents. 
Results 
From a total of 18 operators involved in the study, 1 operator did not qualify 
due to refusal to perform right transradial procedures and 3 operators declined 
participation due to impossibilityto provide representatives pictures while the 
recruitment in the RAD-MATRIX trial took place.  
Overall, the 14 included operators performed 139 procedures (10 ± 7 
procedures per operator) through the right transradial access. Among these operators, 
there was a more than 12-fold variability in the procedural radiation exposure at 
thorax level (Range: 21.5 µSv to 267 µSv)and a roughly five-fold difference for 
DAP (Range: 37 Gy*cm
2
 to 167 Gy*cm
2
). After normalization of radiation dose by 
DAP, a 10-fold inter-operator variability still persisted ranging from 0.35 
µSv/Gy*cm
2
 to 3.5 µSv/Gy*cm
2
.  
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Patient preparation and operator dose 
Six operators arranged the patient right arm along the patient right leg (Group 
A) whereas 8 operators were used to install the patient right arm far from the body 
(Group B). The two groups did not differ significantly for clinical and procedural 
characteristics except for a higher STEMI rate in group A(Table I). 
In group A, the operator procedural radiation dose at thorax level was 
significantly lower compared to Group B (46.1 µSv, IQR 31.3-56.8 µSv and 110.4 
µSv, IQR 71.5-146.5 µSv, respectively, p= 0.02). After normalization by DAP the 
difference still persisted (0.55µSv/Gy*cm
2
, IQR 0.49-0.62 µSv/Gy*cm
2
, in Group A 
and 0.91µSv/Gy*cm
2
, IQR 0.73-1.24 µSv/Gy*cm
2
, in Group B, p= 0.028). Similar 
results were observed at head level whereas at left wrist despite numerically higher 
level in Group B, the difference was not statistically significant (Table II). 
Dimension of the upper mobile leaded glass 
The three operators who used the full glass shield had a significantly higher 
radiation dose compared to the 11 operators that used the combined (glass and 
curtain) shield (147.5 µSv, IQR 135.5-207.3 µSv and 60 µSv, IQR 44.1-73.8 µSv 
respectively, p= 0.016). After normalization by DAP a trend was still noted towards 
higher radiation dose in operators using full glass shield (1.05 µSv/Gy*cm
2
, IQR 0.9-
2.28 µSv/Gy*cm
2
, vs0.71 µSv/Gy*cm
2
, IQR 0.48-0.76 µSv/Gy*cm
2
, p= 0.07). 
 
Discussion 
At variance with transfemoral access, transradial procedures are associated 
with a large variability across centres in term of patient preparation and radio-
protective measures used during catheterization. 
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In the setting of the largest study evaluating the radiation exposure in patients 
and operators during percutaneous coronary interventions with radial or femoral 
access we previously reported that radial, especially when access in the right arm, as 
compared with femoral access is associated with greater operator and patient 
radiation exposure. The key and novel information provided by this study is that a 
different patient set-up for percutaneous coronary procedures through the right radial 
access hasa remarkably large impact on the operator radiation exposure. The lower 
operator exposure was observed when the instrumented right arm was positioned 
along the right leg as compared to operators instrumenting the right radial arm while 
abducted from the thorax.  
Our findings are independent from the anthropometric patient characteristics 
or procedural radiation dose since these observations have been confirmed when the 
operator radiation dose was normalized by DAP.  
The possible explanation of this difference in radiation dose between the two 
set-upsis based on the different use of the upper mobile shield in the two 
arrangements. Indeed in case of external position of the patient arm the operator 
generally place the upper mobile shield morelaterally, in a position that could be less 
effective(Figure 3, Panel A). Differently, when the arm is placed along and very 
close to the right leg the operator has no difficulty to place the upper shield more 
medially increasing its efficacy as radiation shield (Figure 3, Panel B). The results 
observed at head and wrist level confirmed our interpretation: previous studies 
showed that the upper mobile shield is very effective to reduce thorax and head 
radiation whereas the efficacy at left wrist level is weak (15-16). 
According to our findings a simple measure as the arm set up before the 
procedure can reduce operator radiation exposure. This measure is cost saving and 
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effective and should be considered for all programs aimed to reduce radiation 
exposure in the cath lab. 
The role of the upper mobile shields in order to reduce operator radiation 
exposure has been observed in different previous studies with a possible dose 
reduction that in some cases reacheseven 90% of the dose (15-16). However, no 
study evaluated the role of dimensions and shape of the shield in term of operator 
radiation exposure. For the first time, in our study, we observed that a combined 
shield with a leaded glass and a leaded curtain is more effective for operator 
radioprotection compared to a full leaded glass shield. Two are the possible reasons 
of this differences: first of all the combined shield is probably more ergonomic and 
can be better adapted to the different patients, whereas the full glass shield 
sometimes cannot cover all the scattered radiation from the patient because of his 
fixed shape. Another possible explanation is the shield dimension. Amongthe centers 
involved in the study, the combined shield was 10 cm longeras compared to the full 
glass shield and this increase in dimension could have had a significant effect on 
operator shielding efficacy.  
Some limitations of our study should be considered. Our study is a secondary 
analysis of the main studyand it was not pre-specified. The number of operators per 
group was limited (in particular for the comparison of the two upper mobile shields) 
which has prevented us from performing multivariable analysis to appraise the 
independent value of each of the two dose determinates investigated in this analysis. 
At the same time the sample size was small and the analysis limited to patients with 
acute coronary syndromes.Another important limitation of our study is the 
observational nature, and consequently our data should be confirmed in a dedicated 
randomized study. 
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Conclusions 
In conclusion, the patient set-up during right transradial procedureswas 
identified as key factor associated to greater operator radiation exposure. In 
particular the patient right arm arrangement close to the right leg and the use of more 
ergonomic and longerupper shields were associated with a lower operator radiation 
exposure. Our findings emphasize the importance of implementing simple preventive 
measures to mitigate the extra risks of radiation exposure with right radial as 
compared with femoral access 
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Figure Legends 
Figure 1: Right arm set-up for transradial percutaneous coronary procedure. 
Two different right arm arrangements have been observed: a right arm positioning 
along the right leg (Panel A) and an external abducted arrangement (Panel B). 
Figure 2: Upper mobile shields. In the centers involved in the study, two different 
upper mobile shields have been utilized: a combined leaded glass with leaded curtain 
screen (Panel A) and a full leaded glass shield (Panel B). 
Figure 3: Positioning of the upper mobile shield.When the patient right arm is 
placed externally, the operator positioned the upper mobile shield laterally (Panel A) 
creating a gap between the shield and the radiation area that exposes operator to the 
scatter radiation coming from the patient (dotted triangle). Differently when the right 
arm is along the leg, the operator positioned the upper shield more medially 
(arrows)blocking most of the scatter radiation coming from the patient (Panel B). 
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Figure 1 
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Figure 3 
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Graphical Abstract 
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Table I. Clinical and procedural characteristics.  
 
 
 
Group A 
(n= 6) 
 
Group B 
(n= 8) 
 
P  
 
Patients (n) 
 
69 
 
68 
 
 
Procedures (n) 69 70  
Male (%) 49 (71) 53 (76) 0.46 
Age (years) 66 ± 8 65 ± 6 0.71 
Height (cm) 171 ± 5 168 ± 4 0.22 
Weight (kg) 80 ± 7 77 ± 5 0.46 
BMI 27 ± 2 27 ± 1 0.96 
STEMI (%) 36 (52) 20 (29) 0.008 
PCI (%) 55 (80) 60 (86) 0.48 
Contrast (ml) 191 ± 40 175 ± 36 0.46 
*Fluoroscopy time (min) 11 (8.5-13.2) 14 (11.5-16.8) 0.09 
*DAP (Gy*cm2) 93 (61-97) 97 (90-127) 0.17 
 
Results expressed asmean with standard deviation or absolute 
numbers and percent in brackets. 
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*Medians with interquartile range 
BMI: Body mass index; DAP: Dose Area Product; PCI: 
percutaneous coronary intervention; STEMI: ST elevation 
myocardial infarction 
Group A: right arm close to the body 
Group B: right arm abducted from the body 
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Table II. Radiation dose absorbed by operators during right radial access.  
 
 
 
Group A 
(n= 6) 
 
Group B 
(n= 8) 
 
P  
 
Operator Dose (µSv) 
 
 
 
 
 
 
   Thorax 46.1 (25.4-64) 110.4 (70.9-147.1) 0.02 
   Left wrist 97 (30-143) 168 (104-302) 0.09 
   Head 15.5 (6.1-26.9) 43.9 (35-54.5) 0.003 
Dose normalized by DAP(µSv/Cy*cm2)    
   Thorax 0.55 (0.46-0.66) 0.91 (0.72-1.6) 0.03 
   Left wrist 1.05 (0.34-2.18) 1.75 (0.91-2.55) 0.30 
   Head 0.25 (0.071-0.28) 0.38 (0.27-0.61) 0.01 
 
Results expressed as medians with interquartile range (25%-75%).  
DAP: Dose Area Product 
Group A: right arm close to the body 
Group B: right arm abducted from the body 
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Highlights 
 Determinants of operator radiation dose in transradial procedures are 
presented 
 Patient set-up is a key factor associated to operator radiation exposure 
 Patient right arm arrangement close to the right leg is associated with lower 
exposure  
 The use of more ergonomic and longer upper shields is associated with 
lower exposure 
